A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain

Completed · Phase 2 · Has a placebo group

Conditions studied: Dysmenorrhea

In brief

This study is being conducted to evaluate the effects of treatment with Seasonique an extended-regimen oral contraceptive that utilizes low dose ethinyl estradiol during the typical hormone-free interval. Patients will receive 13 weeks of treatment with the option to extend blinded therapy for an additional 13 weeks. The overall study duration will be 6-9 months. Patients will be required to record menstrual pain in a daily diary.

Key facts

Study ID
NCT00196313
Run by
Duramed Research
People needed
95
Starts
2005-05-01
Expected to finish
2008-10-01
Last updated by the study team
2016-09-22

Who can join

Age: any, up to 17. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.